The Cooper Companies Inc (COO)
85.90
+0.39
(+0.46%)
USD |
NASDAQ |
Jul 05, 16:00
85.90
0.00 (0.00%)
After-Hours: 20:00
Cooper Research and Development Expense (Annual): 137.40M for Oct. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| October 31, 2023 | 137.40M |
| October 31, 2022 | 110.30M |
| October 31, 2021 | 92.70M |
| October 31, 2020 | 93.30M |
| October 31, 2019 | 86.70M |
| October 31, 2018 | 84.80M |
| October 31, 2017 | 69.20M |
| October 31, 2016 | 65.40M |
| October 31, 2015 | 69.60M |
| October 31, 2014 | 66.26M |
| October 31, 2013 | 58.83M |
| October 31, 2012 | 51.73M |
| October 31, 2011 | 43.58M |
| October 31, 2010 | 35.27M |
| October 31, 2009 | 33.30M |
| Date | Value |
|---|---|
| October 31, 2008 | 35.47M |
| October 31, 2007 | 39.86M |
| October 31, 2006 | 34.55M |
| October 31, 2005 | 42.88M |
| October 31, 2004 | 6.493M |
| October 31, 2003 | 5.573M |
| October 31, 2002 | 4.315M |
| October 31, 2001 | 3.658M |
| October 31, 2000 | 2.711M |
| October 31, 1999 | 1.977M |
| October 31, 1998 | 1.90M |
| October 31, 1997 | 1.70M |
| October 31, 1996 | 1.20M |
| October 31, 1995 | 2.90M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
86.70M
Minimum
2019
137.40M
Maximum
2023
104.08M
Average
93.30M
Median
2020
Research and Development Expense (Annual) Benchmarks
| Anika Therapeutics Inc | 32.69M |
| Staar Surgical Co | 44.40M |
| OrthoPediatrics Corp | 10.20M |
| NexGel Inc | 0.103M |
| Innovative Eyewear Inc | 0.6622M |